Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of Head and Neck cancers

Figure 2

The effect of Tyrosine kinase inhibition on cellular proliferation determined by MTT assay: (A) the effects of increasing concentrations of gefitinib on growth of ACCS, ACCS-AS and NA-SCC cells are shown. Cells were incubated with vehicle, i.e., non-stimulated, or increasing concentration of gefitinib for 24, 48, and 72 hours. (B) Comparison of cellular growth in response to gefitinib (3.75 μM), EGF (100 ng/ml) and vehicle i.e., non-stimulated. The bars represent SD of results of separate wells. * p < 0.05, versus similar dosage in parental ACCS cells at 24 and 48 hrs. ** p < 0.05, versus similar dosage in ACCS cells at 24 and 48 hrs.

Back to article page